Skip to main content

Table 1 Mean arterial blood pressure (mABP; mmHg), plasma glucose (mg/dl), and glycosylated hemoglobin (HbA1c, %)

From: Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition

Group

mABP (mmHg)

Plasma glucose (mg/dL)

HbA1c (%)

control

103.1 ± 3.57

101.8 ± 4.89

3.68 ± 0.17

con+cur300

106.18 ± 3.93NS

106.8 ± 0.92NS

4.08 ± 0.41NS

DM

151.67 ± 9.68**

459.0 ± 24.40**

10.73 ± 0.32**

DM+cur30

128.33 ± 3.57

360.8 ± 35.82**

8.20 ± 0.88**, †

DM+cur300

122.27 ± 8.68†

310.00 ± 32.73**, †

7.90 ± 0.97**, †

  1. Values are means ± SEM (n = 10) from the groups of: 12-week STZ (DM), diabetes treated with curcumin (DM+cur30, DM+cur300), controls (con) and controls treated with curcumin (con+cur300). NS, no significant difference compared to control, **P < 0.01, significant difference compared to control and control treated with curcumin; † P < 0.05, significant difference from diabetic rats.